Ocala GI Research is a clinical research site located in Ocala, Florida, United States 34471.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Ocala GI Research has participated in 13 clinical trials with 7 currently active.
Therapeutic areas: Non-alcoholic Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis, Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease.
Sponsors: Novo Nordisk A/S, Eccogene, Sagimet Biosciences Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Ocala
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ocala GI Research has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ocala GI Research has 13 clinical trials on record, with 7 currently active. Their work covers Non-alcoholic Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis, Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease.
Ocala GI Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.